Sector Unicycive Therapeutics, Inc.

Aandelen

UNCY

US90466Y2028

Biotechnologie & Medisch Onderzoek

Geschatte realtime 18:33:01 29-10-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
3,795 USD +0,93% Intraday-grafiek van Unicycive Therapeutics, Inc. -3,30% -33,97%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
+0,93%-3,30%-16,26%-19,62%-33,97%-20,62%-37,78%-86,82% - 105 mln.
+0,34%-3,03%-11,69%+16,15%+57,65%+37,45%+61,06%+6,44% - 64,14 mld.
+0,98%+2,68%-5,19%+3,71%+12,22%+12,25%+83,90%+210,70%+5.645,71% 55,53 mld.
+1,75%+2,01%+9,73%+11,48%+19,15%+13,30%+105,71%-14,63%+243,04% 53,03 mld.
-1,46%-1,27%+2,16%+11,00%+21,91%+26,15%+55,11%+5,11%+283,04% 45,99 mld.
-0,86%-3,14%+1,37%+13,16%+21,88%+17,60%+98,42%+3,51%+1.013,94% 42,45 mld.
+0,19%+0,92%-7,36%+4,70%+137,82%+226,48%+932,29%+543,65% - 40,45 mld.
-0,26%-4,20%+6,17%+6,71%+9,81%+10,86%+45,18%+6,84%+157,79% 32,25 mld.
-2,07%+42,73%+63,49%+102,89%+86,88%+103,77%+90,26%+31,35%+238,82% 34,47 mld.
-2,72%-8,79%-15,62%+16,80%+43,32%+22,58%-5,63%-60,89% - 24,23 mld.
+0,27%-1,42%-10,32%-4,90%-7,14%-14,47%-5,20%-68,28% - 22,1 mld.
+14,53%+15,85%-4,76%+6,80%-36,72%-34,03%+362,73%+265,27%+748,46% 21,18 mld.
-1,09%+4,77%+10,13%+17,13%+21,99%+17,20%+183,35%+202,42%+2.260,92% 19,38 mld.
+0,98%+11,49%+27,95%+61,27%+89,83%+110,20%+130,17%-15,60%+399,04% 17,85 mld.
+0,97%+4,59%+14,28%+26,86%+39,55%+43,70%+86,35%-14,58%+110,39% 16,69 mld.
-0,80%+0,80%+12,25%+18,99%+50,21%+66,97%+225,27%+206,07%+521,67% 16,42 mld.
+0,71%+3,22%+9,97%-0,49% - - - - - 16,39 mld.
+3,33%+5,53%+7,36%+11,21%+192,66%+175,10%+360,46%+1.478,53%+825,12% 15,33 mld.
+1,11%+16,65%+26,97%+21,39%+18,70%+30,34%-9,17%-24,57%+169,43% 16,04 mld.
+0,97%-7,48%-3,82%-13,90%+11,63%+3,79%+468,94% - - 13,21 mld.
Gemiddelde +0,87%+3,53%+5,84%+15,57%+39,86%+44,66%+170,08%+148,58%+970,57% 28,36 mld.
Gewogen gemiddelde per kap. +0,55%+3,36%+4,95%+17,31%+42,20%+46,62%+169,17%+124,04%+1.263,06%
  1. Beurs
  2. Aandelen
  3. Koers UNCY
  4. Sector Unicycive Therapeutics, Inc.